Non-Hodgkin lymphoma Trials in Barcelona, Spain
Conditions / Non-Hodgkin lymphoma / Barcelona, Spain
Research into Non-Hodgkin lymphoma spans multiple therapeutic approaches and trial phases.
25 total trials for this combination
Showing top 10 of 25 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03570892 | Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04553692 | Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers | TERMINATED | PHASE1 |
| NCT05006716 | A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | RECRUITING | — |
| NCT03212404 | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05544019 | Study of SGR-1505 in Mature B-Cell Neoplasms | RECRUITING | PHASE1 |
| NCT03422679 | Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies | TERMINATED | PHASE1/PHASE2 |
| NCT01777152 | ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas | COMPLETED | PHASE3 |
| NCT04068597 | Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies | RECRUITING | PHASE1/PHASE2 |
| NCT03573310 | A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS | COMPLETED | PHASE1 |
| NCT03768505 | Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) | TERMINATED | PHASE2 |